Excess cholesterol is known to form artery-clogging plaques that can lead to stroke, arterial disease, heart attack, and more, making it the focus of many heart health campaigns. Fortunately, this attention to cholesterol has prompted the development of cholesterol-lowering drugs called statins and lifestyle interventions like dietary and exercise regimens. But what if there's more…

Popular anti-obesity drugs continue to show cardiovascular benefits beyond weight loss, according to several new papers published in JACC, the flagship journal of the American College of Cardiology, that are being simultaneously presented at the American Heart Association's 2024 Scientific Sessions. JACC is publishing two secondary analyses on the impact of GLP-1 medications in improving…

While exercise is generally beneficial for a person's overall health, physical activities may increase the risk of adverse cardiovascular disease events in certain susceptible individuals. However, cardiologists say that the benefits outweigh the risks. Findings from new data reviews in studies appearing in CJC Open and the Canadian Journal of Cardiology, published by Elsevier, detail…

A competitive swimming program developed by University of Queensland researchers for young people with severe cerebral palsy has reversed motor decline associated with the condition. Professor Sean Tweedy from UQ's School of Human Movement and Nutrition Sciences and the Queensland Centre for Olympic and Paralympic Studies leads the ParaSTART program, a…

Many parents are all too familiar with angry outbursts from their children, from sibling squabbles to protests over screen time limits. But some parents may find it challenging to help their kids manage intense emotions. One in seven think their child gets angrier than peers of the same age and four in 10 say their…

While coronary heart disease and diabetes are often seen in the same patients, a diagnosis of diabetes does not necessarily mean that patients also have coronary heart disease, according to a new study from researchers at Intermountain Health in Salt Lake City. The Intermountain study found that proactively screening patients with diabetes 1 and 2…

In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking tirzepatide for up to 3 years had a reduced combined risk of worsening heart failure events and cardiovascular death, and improved health status and physical function in comparison to participants taking placebo, according to late-breaking science presented today at…

Type 2 diabetes can lead to diabetic kidney disease, but a class of drugs that cause the kidneys to remove glucose through urine has been gaining attention. An Osaka Metropolitan University-led research group has investigated how such drugs maintain kidney health. Known as SGLT2 (sodium-glucose cotransporter-2) inhibitors, the drugs are used to treat type 2…

The total number of adults living with either type 1 or type 2 diabetes in the world has surpassed 800 million - over four times the total number in 1990, according to findings from a global analysis published ahead of World Diabetes Day in The Lancet. Additionally, 445 million adults aged 30 years and older with diabetes (59%) did not receive treatment in 2022, three and a half times the number in 1990. Of the 828 million adults with diabetes in 2022, over a quarter (212…

More time spent sitting, reclining or lying down during the day may increase the risk of cardiovascular disease (CVD) and death, according to a study in JACC, the flagship journal of the American College of Cardiology, and presented at the American Heart Association's Scientific Sessions 2024. More than roughly 10-and-a-half hours of sedentary behavior per…